McKesson | MCK - Sales Revenues

Stock Price
957.80
Daily Change
135.80 16.52%
Monthly
15.88%
Yearly
59.70%
Q1 Forecast
805.61

McKesson reported $106.16B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Acadia Healthcare USD 851.6M 17.6M Sep/2025
Align Technology USD 1.05B 54.3M Dec/2025
Cardinal Health USD 65.63B 1.63B Dec/2025
Centene USD 49.69B 950M Sep/2025
Charles River Laboratories USD 1000M 32.14M Sep/2025
Cigna USD 72.47B 2.77B Dec/2025
CVS Health USD 102.9B 3.99B Sep/2025
DaVita Healthcare Partners USD 3.62B 200M Dec/2025
Dentsply International USD 904M 32M Sep/2025
Elevance Health USD 49.3B 790M Dec/2025
Encompass Health USD 1.54B 60M Dec/2025
HCA USD 19.51B 350M Dec/2025
Henry Schein USD 3.34B 100M Sep/2025
Humana USD 32.65B 260M Sep/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
J&J USD 24.6B 610M Dec/2025
Laboratory Of America USD 3.56B 30M Sep/2025
McKesson USD 106.16B 3.01B Dec/2025
Molina Healthcare USD 11.38B 100M Dec/2025
Owens Minor USD 697.26M 15.36M Sep/2025
Quest Diagnostics USD 2.82B 60M Sep/2025
Stryker USD 7.2B 1.14B Dec/2025
Tenet Healthcare USD 5.29B 20M Sep/2025
UnitedHealth USD 113.2B 0 Dec/2025
Universal Health Services USD 4.5B 220M Sep/2025